Clinical trials: Reading
Reading Disability
Neurocognitive Factors in EdTech Intervention Response
The current project will carry out a large-scale, randomized controlled trial (RCT) to examine the effectiveness of a home-administered technology-based treatment for reading disability (GraphoLearn) in a diagnostically diverse…
- Trial name
- NCT04568824
- Testing
- GraphoLearn reading intervention, Math control intervention
- Where
- United States
- Volunteers
- 315 people, healthy volunteers welcome
- Sponsor
- University of Connecticut
Reading Learning Disability, Math Learning Disability
Improving the Academic Performance of First-Grade Students With Reading and Math Difficulty
The main purpose of this clinical trials is to explore short-term effects of coordinated intervention versus the business-as-usual school program on the primary endpoints of post-intervention word-reading fluency and arithmetic…
- Trial name
- NCT03991234
- Testing
- Reading Intervention, Math Intervention, Coordinated Intervention
- Where
- United States
- Volunteers
- 385 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University
Neurofibromatosis Type 1, Reading Disabilities
Neurobiology and Treatment of Reading Disability in NF-1
The goal of this trial is to determine if children with neurofibromatosis type 1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs as children with…
- Trial name
- NCT00624234
- Testing
- Tutoring Program I, Tutoring Program II
- Where
- United States
- Volunteers
- 184 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University
Reading Problem
Knowledge Accessibility and Availability in Forming Knowledge-to-Text Inferences Among Middle Grade Readers
Recent adolescent-based research shows that inference making improves across grades 6-12, uniquely accounts for variance in sentence- and passage-level comprehension, and that individual differences in inference making relate in…
- Trial name
- BVU-R15 (NCT03782012)
- Testing
- Supported
- Where
- United States
- Volunteers
- 241 people, healthy volunteers welcome
- Sponsor
- Buena Vista University
Attention Deficit Hyperactivity Disorder, Reading Disorder
Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
To test the hypothesis that a 4 week treatment with atomoxetine is more effective than placebo in patients with combined type Attention Deficit/Hyperactivity Disorder (ADHD), patients with only Reading Disorder, and patients with…
- Trial name
- NCT00191906
- Testing
- Atomoxetine Hydrochloride
- Where
- 5 sites in Belgium, Netherlands
- Volunteers
- 121 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company